FRI0318 Serum URIC Acid as an Independent Risk Factor on Progression of Chronic Kidney Disease in Gout Patients with URIC Acid Lowering Agent

BackgroundHyperuricemia is particularly common in patients with chronic kidney disease (CKD). Its role, however, as a risk factor for renal outcomes of CKD is debated and those data in gout patients with CKD are rare.ObjectivesThis aim of study was to evaluate long-term effect of serum uric acid (SU...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2015-06, Vol.74 (Suppl 2), p.539-539
Hauptverfasser: Park, E.-J., Hee, E.Y., Lee, S., Hwang, J., Kwon, E.-J., Kim, J., Koh, E.-M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundHyperuricemia is particularly common in patients with chronic kidney disease (CKD). Its role, however, as a risk factor for renal outcomes of CKD is debated and those data in gout patients with CKD are rare.ObjectivesThis aim of study was to evaluate long-term effect of serum uric acid (SUA) level on progression of CKD in gout patients with uric acid lowering treatment.MethodsAll patients who had a first visit for gout with CKD at Samsung Medical Center between 1995 and 2003, and follow-up until December 2012 or expired during follow-up period were included and retrospective analyzed. CKD was defined as an estimated glomerular filtration rate GFR) of
ISSN:0003-4967
1468-2060
DOI:10.1136/annrheumdis-2015-eular.5785